New Wave

Walk down the supplement aisle and you're faced with rows of promises, but who is proving them? This episode follows Nature's Way Canada's quiet rebellion: swapping hype for evidence, marketing for education, and fishy burps for something people actually want to take. Guest bios & credentials: - Tsege Gebreyohannes - Director of Brand & Digital, Nature's Way Canada. Hosted on Acast. See acast.com/privacy for more information.

One in two of us will face cancer. This episode follows a Nova Scotian scientist who discovered ALDH1A3 and risked everything to try to turn it into a therapy. Episode breakdown & timestamps: 00:00 — Cold statistic and the stakes: why every cancer discovery matters. We open with the brutal reality: despite promising lab results, only ~10% of discoveries become human therapies. 02:00 — The enemy explained. Dr. Paola Marcato breaks down what cancer and metastasis really are and why targeting spread is critical. 06:00 — The scientist’s path. Paola’s pivot from bacterial research to oncology, mentorship at Dalhousie, and the moment the lab “whispered” a secret. 12:00 — The discovery: ALDH1A3 — a supercharger enzyme linked to aggressive, treatment‑resistant tumours and why it matters for precision medicine. 14:30 — The choice: translate to a drug or stay in the lab. The moral, financial and scientific risks of starting Theranib in Nova Scotia. Guest bio & credentials: Dr. Paola Marcato — cancer biologist at Dalhousie University and co‑founder of Theranib. Her work identified ALDH1A3 as a driver of aggressive, metastatic cancer phenotypes and sparked a translational effort to develop targeted therapies. Hosted on Acast. See acast.com/privacy for more information.

What if the next medical cannabis breakthrough wasn't in a lab but in a basement with 3,000 koi? In this episode we trace how Aqualitas created an aquaponic ecosystem that caught the eye of a global cannabis distributer and helped them transform their business. Episode breakdown & timestamps: 00:00 — Opening: The unlikely origins of big medical innovation (intro to the central mystery and stakes). 02:20 — From hockey rinks to hedge funds to cannabis: Josh Roberts' journey and why Wellford pursued Aqualitas (founder & investor perspective). 06:30 — Meet the scientist: Danielle Maitland explains aquaponics vs hydroponics and the living ecosystem that fuels plants. 10:15 — Inside Aqualitas: the basement system, 3,000 koi, recirculating aquaculture, and the water chemistry that changes product quality. 13:30 — Business & science meet: why aquaponics creates a defensible moat, R&D hurdles, and the global response. 16:30 — Takeaways, implications for sustainable cultivation, and what's next for Nova Scotia's life sciences scene. Guest bios & credentials: - Danielle Maitland — Director of Science & Cultivation Technology, Aqualitas. Background: chemical engineering, MSc in sustainable aquaculture, PhD candidate in agricultural sciences; expert in aquaponics and plant–microbe interactions. - Josh Roberts — Chief Business Officer, Wellford Group. Former hedge fund trader and co-founder of Cannaray/Wellford What you'll learn: - How aquaponics works and why it can outperform hydroponics for cannabis: closed-loop water, nutrient cycling, and beneficial microbes. - The sustainability gains: 90–95% water recirculation, reduced synthetic fertilizers, and lower energy/resource footprint. - Commercial and regulatory implications: why unique cultivation methods create supply-chain advantages and differentiation for medical cannabis. - Lessons for founders and investors: the power of deep R&D, place-based innovation (Nova Scotia), and vertical integration strategies. Resources & links mentioned: - Aqualitas: https://aqualitas.ca - Wellford Group / Cannaray: https://wellford.com - Life Sciences Nova Scotia: https://lifesciencesnovascotia.ca - Snack Labs: https://wearesnack.io - Intro reading on aquaponics vs hydroponics: https://en.wikipedia.org/wiki/Aquaponics Hosted on Acast. See acast.com/privacy for more information.

In this episode of New Wave, we trace Dr. Abdullah "Dr. K" Kirumira's extraordinary path from 1970s Uganda to Windsor, Nova Scotia — and how his decades of cross-disciplinary biotech work produced Bioteem 40, a probiotic supplement designed to meet real-world nutrition and gut-health challenges. We explore the science behind the microbiome, the social and medical drivers of a global gut-health crisis, and why a simple, durable design matters for healthcare everywhere. Episode timestamps & highlights: 00:00 — Opening hook: Gut as the "second brain" and the stakes for modern health 02:20 — Teaser: What Bioteem 40 promises that other probiotics don’t 03:30 — Introducing Therapy Bios Pharma and Dr. Abdullah Kirumira ("Dr. K") 05:30 — Origin story: escaping Idi Amin’s Uganda and the pivot from dentistry to food tech 11:00 — Science deep-dive: fermentation, dry-reagent chemistry, and medical diagnostics 15:30 — The innovation: how Bioteem 40 works differently (stability, strains, delivery) 20:00 — Real-world impact: malnutrition, elderly care, mental health connections 25:00 — What’s next: commercialization, clinical trials, and global distribution 28:30 — Key takeaways, final thoughts, and calls-to-action Guest bio & credentials: Dr. Abdullah Kirumira (Dr. K) — President & CEO, Therapy Bios Pharma (Windsor, NS). Trained in dentistry and food processing technology; postgraduate work in the U.S. (University of Maryland) and Australia; decades of work in fermentation, industrial and medical biotechnology, and dry-reagent diagnostics. A survivor of political violence in Uganda whose career spans diagnostics, probiotics, and practical healthcare solutions for low-resource settings. Links & resources mentioned: - Bioteem 40 product page: https://bioteem40.ca - Life Sciences Nova Scotia: https://lifesciencesnovascotia.ca - Read more on microbiome basics: https://www.nature.com/subjects/microbiome (reference) Hosted on Acast. See acast.com/privacy for more information.

A frozen vial, a lifesaving diagnosis: how a Nova Scotia company reimagined bleeding tests and changed outcomes worldwide. In this episode of New Wave we unpack how Precision Biologic turned a simple customer insight - freeze the reagent - into a global shift in hemostasis diagnostics. Episode breakdown & timestamps - 00:00 Hook & scene: the everyday miracle of blood clotting and why it matters. (00:00) - 01:48 Show intro & mission: New Wave, Life Sciences Nova Scotia & Snack Labs. (01:48) - 02:07 The clotting cascade explained: Dr. John Geske walks us through the 13-step process and why each factor matters for diagnosis. (02:07) - 06:55 Athlete story: Alex Dowsett on living with severe hemophilia A and the stakes of timely testing. (06:55) - 12:10 Diagnostic delays and family stories: why unreliable tests cost years of life and peace of mind. (12:10) - 13:48 The breakthrough: Precision Biologic’s frozen (cryopreserved) reagent strategy and product story. (13:48) - 17:31 Cold chain & scale: liquid nitrogen, dry ice, logistics and global distribution challenges. (17:31) - 19:31 Systems impact: how accurate diagnostics reduce costly treatment errors and protect health budgets. (19:31) - 22:00 Closing: regulation, persistence, and what comes next for diagnostics innovation. (22:00) Guests & bios - Dr. John Geske — Chief Scientific Officer, Precision Biologic. He explains the science behind hemostasis, the technical hurdles for reagents, and why frozen plasma-based controls changed lab workflows. - Paul Empy — CEO, Precision Biologic. Describes customer discovery, product strategy, and the company’s operational choices. - Alex Dowsett — Professional cyclist and person living with severe hemophilia A. His story humanizes diagnostic urgency. Key takeaways & memorable quotes - "A frozen vial of plasma" became the phrase that reminded the company of the lives their work touches. - Frozen liquid reagents eliminate a high-risk, error-prone reconstitution step in labs—improving accuracy, speed, and patient safety. - Accurate diagnostics lower system-wide costs (avoiding unnecessary $10,000 drug switches) and speed correct treatments. - Quote: "If you do this work once under perfect conditions and ship it frozen, you remove human error at the bench." Why this matters This episode explores diagnostic innovation, frozen reagents, hemostasis labs, hemophilia diagnostics, cold-chain logistics, and patient-centered product design. Target keywords include frozen diagnostics, hemophilia testing, precision biologic, cryo reagents, and Nova Scotia life sciences. Call-to-action If you found this episode illuminating, subscribe to New Wave, rate & review on Apple Podcasts or Spotify, and share with colleagues in lab medicine. Links & resources mentioned - Precision Biologic: https://precisionbiologic.com - Life Sciences Nova Scotia: https://lifesciencesnovascotia.ca/ - Snack Labs podcast production: https://wearesnack.io - World Federation of Hemophilia (patient resources): https://www.wfh.org Show branding & social handles New Wave — stories about life sciences and health tech from Nova Scotia. Follow: Life Sciences Nova Scotia (LinkedIn) | @snackpodcasts (instagram | Precision BioLogic (LinkedIn) This episode blends investigative reporting with scientific explanation and patient stories to reveal how a small operational change—freezing reagents—reduced diagnostic risk and improved outcomes worldwide. Perfect for clinicians, lab directors, biotech founders, and anyone interested in relatable science and systems-level healthcare impact. Hosted on Acast. See acast.com/privacy for more information.

We've all heard of ultrasound, but what you likely haven't heard of is the mind bending sci-fi future of an established technology that's been in the works for decades. On this episode of New Wave, we're speaking with Jeff Leadbetter from Daxsonics Ultrasound about how his company helps top medical minds bring revolutionary ultrasound research to life in a way that will blow you away. From burning lesions in the brain to wipe out neurological disorders, to scalpels that don't have to cut through skin, welcome to the world of ultrasound you didn't know existed. New Wave is produced by Snack Labs. It is written & narrated by Taylor MacGillivary. New Wave is edited by, Jeremie Saunders, Brian Stever and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fueling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Standardization reigns supreme in the world of science, but when it comes to drug development, a Nova Scotian company is challenging the status quo. Patient centred outcomes have been identified by the FDA as a clinical trials tool that needs more attention, and Ardea Outcomes is doing just that. Building off of the foundation of Goal Attainment Scaling, a method pioneered in the 1960s to help treat patients struggling with mental health challenges, Ardea Outcomes is helping create objective data from subjective experience and putting patients at the centre of their own treatment. New Wave is produced by Snack Labs. It is written & narrated by Taylor MacGillivary. New Wave is edited by, Jeremie Saunders, Brian Stever and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fuelling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Eric Hoffman's academic career began in the artistic arena of music, and ended at the bleeding edge of the genetic revolution. in 1987, he discovered the very first disease causing gene...the gene responsible for Muscular Dystrophy. With grit and determination, Eric dedicated his professional life to turning a scientific discovery into treatments that can actually change lives, and he is tireless in that pursuit. Join us as we learn how AGADA Biosciences has become the silent partner in the global fight against Musular Dystrophy, and how Alexei, who has lived with MD since childhood, has struggled, and defied the odds, with a disease that doesn't quit. New Wave is produced by Snack Labs. It is written & narrated by Taylor MacGillivary. New Wave is edited by, Jeremie Saunders, Brian Stever and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fueling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Our eyes evolved in sunlight, and sunlight is something we are exposed to less and less as our technological world puts us indoors and in front of screens more and more each day. Enter Coloursmith, a Nova Scotian company that has broken through a barrier of innovation in contact lense technology, enabling a level of colour filtration that has been virtually impossible to achieve, until now. Join us as we dive into the Myopia epidemic that is spreading across the globe at an alarming rate, and how colour filtration could lend a hand in curbing a vision crisis that has been lurking right before our eyes. New Wave is produced by Snack Labs. It is written & narrated by Taylor MacGillivary. New Wave is edited by, Jeremie Saunders, Brian Stever and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fueling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Every day, 17 people in the United States die while waiting for an organ transplant. We're a great distance away from creating funtioning, complex organs from scratch, but it's a sci-fi future that we're convinced is coming. An integral part of bringing that future to life, is collagen. Collagen is like the scaffolding on which this future will be built, literally AND figuratively, and there's a company in Nova Scotia that has unlocked the door, for the first time, to scalable and affordable collagen production. The company, is 3D BioFibr. New Wave is produced by Snack Labs. It is narrated Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fuelling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Do you want to live past 75? If the answer to that question seems obvious, consider that the average human, at this point in time, will face a 16 year decline, beginning in their early 60s, until the end of their lifespan in their late 70s. This is the difference between what we call lifespan and healthspan. Luckily for us, there's an industry of longevity that has been gaining steam over the past decade or more, and part of that longevity industry is Altheda Wellness. Join us as we speak with CEO Chris MacLean and CSO Melanie Kelly from Altheda Wellness and learn how they're developing nutraceuticals to help the elderly population stretch out their healthspan by working on the issues that put their health the most at risk. New Wave is produced by Snack Labs. It is narrated Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fuelling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

If you've ever been referred to a medical specialist, you probably waited a very...long...time. Waiting to see specialists is a bottleneck in the Canadian healthcare system that is crippling it from the bottom up, but there's one Nova Scotian company who's determined to help solve it. Virtual Hallway is a software platform that connects primary care providers to specialists across the vast spetrum of medical specialties, creating medical solutions for people in a week, instead of 18 months. New Wave is produced by Snack Labs. It is narrated Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fuelling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Orthopaedic surgery has made leaps and bounds in the 20th and 21st centuries, but the surgical solutions for one of the most common shoulder injuries continues to fall short for patients who rely on them. That injury is called a Massive Irepperable Rotator Cuff Tear. This episode of New Wave explores the innovations of a Nova Scotia company, Reach Orthopaedics, that is on a mission to revolutionize the treatment of MIRCT's with their proprietary implant. It's aim is to end that choice that patients must make between a surgical option that lasts versus a surgical option that restores function, finally giving them, the best of both worlds. New Wave is produced by Snack Labs. It is narrated Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fuelling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Are the two most dominate meal replacement drinks in the world...actually good for you? On this week's episode, we're diving into, Sperri, a purpose driven nutrition company from Nova Scotia, their mission to disrupt a global duopoly, reduce costs for healthcare systems, and provide people and patients in need the right ingredients, and the right nutrition, to get better. New Wave is produced by Snack Labs. It is narrated Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fuelling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Could a pocket-sized device revolutionize hospital safety? Imagine an IV that communicates with doctors, preventing potentially life-threatening errors. In this captivating episode of New Wave, we dive into the innovative world of FIVAmed, a small but ambitious Nova Scotian company that's reshaping IV therapy safety. Join host Taylor MacGillivary as we explore the game-changing technology behind FIVAmed's clip-on gadget. Discover how this ingenious device not only prevents air embolisms—a rare but devastating complication—but also ensures precise drug delivery, potentially transforming patient care in hospitals worldwide. From the device's origin story to its cutting-edge features, we unpack how FIVAmed is addressing critical issues in IV therapy. Learn about the challenges of gravity-fed IVs, the implications of drug over- and underdosing, and how this innovative technology could provide an extra layer of safety even alongside existing infusion pumps. This episode offers a fascinating glimpse into the intersection of medical innovation and entrepreneurship, showcasing how a small team from Nova Scotia is tackling a global healthcare challenge. Whether you're a healthcare professional, a tech enthusiast, or simply curious about the future of patient safety, this episode promises insights that will change how you think about hospital care. Tune in to New Wave for a story of innovation, perseverance, and the potential to save lives—one IV at a time. New Wave is produced by Snack Labs. It is narrated by Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fueling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

What is polymorphism? And what does it have to do with a crucial HIV/AIDS treatment that pulled from the shelves in the late 90s, and a Nova Scotia company, Solid State Pharma, that is empowering pharmaceutical companies across the globe to make the most stable and accessible products possible? In today's episode of New Wave, find out how the crystal structure of drug compounds lead to optimal performance in the patients that need them, and how Solid State Pharma's talented team of scientists make it happen. New Wave is produced by Snack Labs. It is narrated Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io . This series is brought to you by Life Sciences Nova Scotia. LSNS is fuelling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca . Hosted on Acast. See acast.com/privacy for more information.

Aruna revolution is a company that is changing the face of menstrual products across the globe. Every year in North America alone, 20 billion menstrual products end up in landfills, where they breakdown into microplastics that poison the earth and the people on it. Aruna Revolution has created the first truly compostable menstrual pad, with an innovative manufacturing process that allows them to leverage useful waste prodcuts and create a product used by billions that will help stop the polluting of our planet, while saving the pad users themselves in the process. New Wave is produced by Snack Labs. It is narrated Taylor MacGillivary and written by Haeley DiRisio and Taylor MacGillivary. New Wave is edited by, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music and sound design is by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia. LSNS is fueling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.

Get ready for an exciting new season of New Wave, where we continue to explore the groundbreaking innovations emerging from Nova Scotia’s thriving life sciences sector. This season, we'll take you even deeper into the world of health and technology, showcasing how local innovators are tackling global challenges with bold, forward-thinking solutions. From cutting-edge materials to revolutionary approaches in biotechnology, Season 2 offers a behind-the-scenes look at the minds shaping our future. These stories of courageous innovation and relentless problem-solving highlight the incredible impact Nova Scotia is making on the world stage. Join us as we embark on this journey of discovery. Season 2 of New Wave launches September 18th, wherever you get your podcasts. Hosted on Acast. See acast.com/privacy for more information.

Hello! As we work hard behind the scenes to bring you Season 2 of New Wave, here's a bonus episode for you to devour in the meantime. This bonus episode is the full conversation between the host of New Wave, Taylor MacGillivary, and co-founder of Adaptiiv Medical Technologies, as well as Professor and Chief of Medical Physics at Dalhousie University's Department of Radiation Oncology, Dr. James Robar. Hosted on Acast. See acast.com/privacy for more information.

At the heart of every industry sector is a very important thread. Where is the money? In the season finale of New Wave, we’re peeling back the curtain on an essential thread that weaves its way through all of the companies that we’ve explored throughout this series. Investment. Peter Hickey shows up in just about every corner of the Life Sciences sector in Nova Scotia, helping companies find investment. Through a grassroots investment community that he and Neil Smith have grown over the years, they’re now formalizing it with the founding of SUMS. Helping companies with corporate governance and instilling trust in investors is the name of the game. Through a web platform that gives investors information typically reserved for publicly traded investments, SUMS is galvanizing the investment community in Nova Scotia, helping the Life Sciences sector thrive. Learn more about SUMS at www.sumscapital.com Peter Hickey is the co-founder of SUMS and has been involved in several successful life sciences companies in Nova Scotia. You can visit his LinkedIn at www.linkedin.com/in/peterghickey/ Dr. Neil Smith is the co-founder of SUMS and also an Otolaryngologist Head & Neck Surgeon, as well as the founder of The Snore Shop. Visit his LinkedIn profile at www.linkedin.com/in/drneilsmith/ New Wave is produced by Snack Labs . It is narrated and written by Taylor MacGillivary and edited by Brian Stever, Jeremie Saunders and Taylor MacGillivary from Snack Labs. Music by Tom Fox and sound design by Donovan Morgan. Find out more about Snack Labs at www.wearesnack.io This series is brought to you by Life Sciences Nova Scotia . LSNS is fueling innovation and commercial success of the life sciences sector in Nova Scotia by amplifying the ambition of founders and visionaries who aim to change the world through the commercialization of game-changing ideas. Learn more about them at www.lifesciencesnovascotia.ca Hosted on Acast. See acast.com/privacy for more information.